Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0043	Subject Initials :F-H	DOB :03/13/1983	Sex:Female	Race:Asian	Height:164cm	Weight:54.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/13/2015		225
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/30/2015	06/05/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Laparoscopic tubal ectopic pregnancy at the right side of the window to take embryo				Uk-Unk-2005	Not on treatment/medication
Under the right fallopian tube ectopic pregnancy laparoscopic surgery				Uk-Unk-2007	Not on treatment/medication

				26-FEB-16
				NA/EMR700623-541/C02-0043
				Page 1 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0046	Subject Initials :Q-H	DOB :10/07/1985	Sex:Female	Race:Asian	Height:161cm	Weight:50.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/13/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/28/2015	06/05/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
Condition				Start Date	Related to study condition	Ongoing

				04-MAR-16
				NA/EMR700623-541/C02-0046
				Page 2 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0049	Subject Initials :HPT	DOB :09/16/1980	Sex:Female	Race:Asian	Height:155cm	Weight:50.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/14/2015		187.5
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/31/2015	06/03/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Laparoscopic surgery appendicitis				Uk-Unk-2012	Not on treatment/medication

				04-MAR-16
				NA/EMR700623-541/C02-0049
				Page 3 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0052	Subject Initials :YLL	DOB :02/07/1992	Sex:Female	Race:Asian	Height:165cm	Weight:54.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/14/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/30/2015	06/05/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
Condition				Start Date	Related to study condition	Ongoing

				04-MAR-16
				NA/EMR700623-541/C02-0052
				Page 4 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0053	Subject Initials :YND	DOB :04/13/1992	Sex:Female	Race:Asian	Height:155cm	Weight:45.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/14/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/30/2015	06/05/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Laparoscopic tubal colostomy, pelvic surgery sticky points.				Uk-Unk-2013	Not on treatment/medication

				04-MAR-16
				NA/EMR700623-541/C02-0053
				Page 5 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0059	Subject Initials :J-L	DOB :12/23/1984	Sex:Female	Race:Asian	Height:155cm	Weight:50.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/14/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/31/2015	06/05/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
Condition				Start Date	Related to study condition	Ongoing

				07-MAR-16
				NA/EMR700623-541/C02-0059
				Page 6 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0062	Subject Initials :FQR	DOB :07/25/1983	Sex:Female	Race:Asian	Height:162cm	Weight:46.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/14/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/30/2015	06/03/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Hysteroscopic tubal inspection				Uk-May-2014	Not on treatment/medication

				07-MAR-16
				NA/EMR700623-541/C02-0062
				Page 7 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0071	Subject Initials :LLX	DOB :07/13/1987	Sex:Female	Race:Asian	Height:157cm	Weight:41.5kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/15/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	05/31/2015	06/05/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event Description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Laparoscopic pelvic sub sticky, sticky points left fallopian tube surgery.				Uk-Unk-2014	Not on treatment/medication

				08-MAR-16
				NA/EMR700623-541/C02-0071
				Page 8 of293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :NA		Country of Investigator :China	SiteNo:C02
Subject No :C02-0115	Subject Initials :KJT	DOB :07/02/1988	Sex:Female	Race:Asian	Height:163cm	Weight:52.0kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	05/21/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	06/06/2015	06/12/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
None(Othervalue:)		Not applicable	Led to study termination	Resolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
HSG examination: bilateral tubal occlusion				Uk-Unk-2012	Not on treatment/medication
Laparoscopy surgery: pelvic sticky points, bilateral tubal ostomy + right side mesosalpinx cyst removal.				Uk-May-2015	Not on treatment/medication

				14-MAR-16
				NA/EMR700623-541/C02-0115
				Page 9 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0010	Subject Initials :Q-Z	DOB :01/31/1990	Sex:Female	Race:Asian	Height:159cm	Weight:45kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/02/2015		225
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	08/17/2015	08/24/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Disease under study,Protocol procedure,Concomitant medication**(Othervalue:)		Dose not changed	Led to study termination	Resolved
Event description:abdominal distention;nausea Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 17-Aug-2015 / 27-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
Condition				Start Date	Related to study condition	Ongoing

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0010
				Page 10 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0013	Subject Initials :L-L	DOB :06/12/1986	Sex:Female	Race:Asian	Height:159cm	Weight:54.5kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/02/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	08/18/2015	08/20/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Disease under study,Protocol procedure,Concomitant medication**(Othervalue:)		Dose not changed	Led to study termination	Resolved
Event description:abdominal distention;nausea ,ascites,Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 18-Aug-2015 / 20-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
ampullary pregnancy				UK-Unk-2010	Not on treatment/medication
ampullary pregnancy				UK-Unk-2012	Not on treatment/medication
ampullary pregnancy				UK-Unk-2013	Not on treatment/medication
salpingocatheterism				UK-Unk-2013	Not on treatment/medication

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0013
				Page 11 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0021	Subject Initials :FYZ	DOB :08/28/1990	Sex:Female	Race:Asian	Height:150cm	Weight:45kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/04/2015		225
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	08/19/2015	08/21/2015		Related	Mild
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Protocol procedure,Concomitant medication(Othervalue:)		Dose not changed	Led to study termination	Resolved
Event description:abdominal distention;Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 19-Aug-2015 / 21-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
salpingocatheterism				UK-Unk-2012	Not on treatment/medication

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0021
				Page 12 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0041	Subject Initials :W-Y	DOB :07/03/1981	Sex:Female	Race:Asian	Height:153cm	Weight:55kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/08/2015		225
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	08/23/2015	08/25/2015		Related	Mild
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Protocol procedure,Concomitant medication(Othervalue:)		Dose not changed	Led to study termination	Resolved
Event description:abdominal distention;Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 21-Aug-2015 / 25-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
Condition				Start Date	Related to study condition	Ongoing

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0041
				Page 13 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0056	Subject Initials :X-P	DOB :06/14/1983	Sex:Female	Race:Asian	Height:158cm	Weight:46kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/13/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	08/27/2015	08/29/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Protocol procedure,Concomitant medication(Othervalue:)		Dose not changed	Led to study termination	Resolved
Event description:abdominal distention;nausea ;ascites;Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 17-Aug-2015 / 27-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
Condition				Start Date	Related to study condition	Ongoing

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0056
				Page 14 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0068	Subject Initials :YPL	DOB :12/07/1985	Sex:Female	Race:Asian	Height:160cm	Weight:50kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/15/2015		225
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	08/27/2015	08/29/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Protocol procedure,Concomitant medication(Othervalue:)		Dose not changed	Led to study termination	Resolved
Event description:abdominal distention;nausea ;ascites;Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 17-Aug-2015 / 27-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Fallopian tube repair anaplasty				UK-Unk-2010	Not on treatment/medication

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0068
				Page 15 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0117	Subject Initials :Y-L	DOB :04/16/1982	Sex:Female	Race:Asian	Height:165cm	Weight:48kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/23/2015		225
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	09/08/2015	09/10/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Protocol procedure,Concomitant medication(Othervalue:)		Dose reduced	Led to study termination	Resolved
Event description:abdominal distention;ascites;Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 19-Aug-2015 / 21-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
Condition				Start Date	Related to study condition	Ongoing

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0117
				Page 16 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR700623-541	Investigator :Ying Zhong		Country of Investigator :China	SiteNo:C05
Subject No :C05-0141	Subject Initials :XHZ	DOB :04/14/1987	Sex:Female	Race:Asian	Height:158cm	Weight:48kg
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Gonal-f New Pen Stimulation Treatment	08/29/2015		150
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
OHSS	09/12/2015	09/14/2015		Related	Moderate
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Protocol procedure,Concomitant medication(Othervalue:)		Dose not changed	Led to study termination	Resolved
Event description:abdominal distention;nausea ;ascites;Drug：Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml，ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 17-Aug-2015 / 27-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Fallopian tube repair anaplasty				UK-Unk-2009	Not on treatment/medication

				01-MAR-16
				Ying Zhong/EMR700623-541/C05-0141
				Page 17 of 293

Non Serious Adverse Drug Reactions Report
Start Date:2016-02-26 End Date:2016-03-14
Study :EMR200136_583	Investigator :NA		Country of Investigator :Romania	SiteNo:007
Subject No :007-0007	Subject Initials :	DOB :08/01/1981	Sex:Female	Race:Caucasian	Height:163(cm)	Weight:60(kg)
First administration date of batch :			Batch number :
Study Drug	Start Date		Dose	Change in Dose
Visit 2 (Month 3)	06/05/2015		9
Visit 3 (Month 6)	06/05/2015		9
Visit 1/ Baseline (Day 1)	06/05/2015		9
Visit 4 (Month 9)	06/05/2016		9
Adverse Event	Start Date	End Date	Time related to study treatment	Causality to study drug	Severity
Adverse event	12/16/2015			Suspected	Mild
Causality Factors		Action Taken with Study Treatment	Other action taken	Outcome	AE Special Interest	AE dose limiting toxicity
Other(Othervalue:Rebif therapy)		Dose not changed	Concomitant medication	Ongoing
Event description:
Subject received concomitant medications:Yes
Name of medication	Start Date	Ongoing	End Date	Dose	Unit	Frequency
Stilnox	06/02/2015	Yes		1	tb	QD
Alanerv	06/06/2015		11/30/2015	2	tb	BID
Acetaminophen	06/05/2015	Yes		500	mg	PRN
L-Thyroxin	Uk-Jan-2016	Yes		25	mcg	QD
Does the subject have any relevant past or present medical conditions:Yes
Condition				Start Date	Related to study condition	Ongoing
Depression						Yes

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report

Non Serious Adverse Drug Reactions Report